ES8703871A1 - Procedimiento de obtener alcaloides del tipo de la berberina y similares. - Google Patents
Procedimiento de obtener alcaloides del tipo de la berberina y similares.Info
- Publication number
- ES8703871A1 ES8703871A1 ES522754A ES522754A ES8703871A1 ES 8703871 A1 ES8703871 A1 ES 8703871A1 ES 522754 A ES522754 A ES 522754A ES 522754 A ES522754 A ES 522754A ES 8703871 A1 ES8703871 A1 ES 8703871A1
- Authority
- ES
- Spain
- Prior art keywords
- decrease
- composition containing
- protoberberine alkaloid
- containing same
- left ventricle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE ALCALOIDES DEL TIPO DE LA BERBERINA Y SIMILARES, EN PARTICULAR, EN LA PREPARACION DE COMPUESTOS DE FORMULA GENERAL (I). COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE SOMETEN LOS PRECURSORES A UNA ETAPA DE SINTESIS; SEGUNDA, SE EFECTUA UNA ETAPA DE DISOLUCION DEL ALCALOIDE Y UNA ETAPA DE AJUSTE DEL PH PARA LLEVARLO A UN VALOR INFERIOR A 7; TERCERA, SE HACE REACCIONAR UNA DISOLUCION DE SULFATO DE BERBERINA CON HIDROXIDO DE BARIO; Y POR ULTIMO, SE TRATA LA DISOLUCION DE LA BASE LIBRE, FUERTEMENTE ALCALINA, CON HIDROXIDO SODICO, PARA OBTENER EL ALDEHIDO. DE APLICACION EN EL TRATAMIENTO Y DIAGNOSTICO DE LOS DESORDENES CIRCULATORIOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37812282A | 1982-05-14 | 1982-05-14 | |
US40988382A | 1982-08-20 | 1982-08-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES522754A0 ES522754A0 (es) | 1987-03-16 |
ES8703871A1 true ES8703871A1 (es) | 1987-03-16 |
Family
ID=27008080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES522754A Expired ES8703871A1 (es) | 1982-05-14 | 1983-05-14 | Procedimiento de obtener alcaloides del tipo de la berberina y similares. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0108147B1 (es) |
AU (1) | AU571184B2 (es) |
CA (1) | CA1220139A (es) |
DE (1) | DE3377695D1 (es) |
ES (1) | ES8703871A1 (es) |
GR (1) | GR79223B (es) |
IE (1) | IE55519B1 (es) |
IL (1) | IL68690A0 (es) |
IT (1) | IT1173712B (es) |
PT (1) | PT76690B (es) |
WO (1) | WO1983003970A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100258849B1 (ko) * | 1998-04-24 | 2000-08-01 | 박원배 | 약학적으로 유용한 프로토베르베린염 유도체 및프로토베르베린유도체와 이의 염 |
CA2467774C (en) | 2001-11-14 | 2011-09-20 | Rutgers, The State University | Solubilized topoisomerase poisons |
DE60225943T2 (de) | 2001-11-14 | 2009-01-29 | Rutgers, The State University | Topoisomerase-giftmittel |
EP1453507B1 (en) | 2001-11-14 | 2009-03-04 | Rutgers, The State University | Solubilized topoisomerase poison agents |
ATE405568T1 (de) | 2001-11-14 | 2008-09-15 | Univ Rutgers | Cytotoxische mittel |
AU2003265406A1 (en) | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted topoisomerase agents |
WO2004014862A1 (en) | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted heterocycles as topoisomerase i targeting agents |
WO2004014906A2 (en) | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
JP4774212B2 (ja) | 2002-11-12 | 2011-09-14 | ラトガーズ、ザ・ステイト・ユニバーシテイ・オブ・ニユー・ジヤージー | トポイソメラーゼ−ターゲッティング剤 |
CN100441183C (zh) * | 2005-08-29 | 2008-12-10 | 中国医学科学院皮肤病研究所 | 盐酸13-己基小檗碱和盐酸13-己基巴马汀制备治疗湿疹、皮炎和银屑病的药物用途 |
JP5773888B2 (ja) | 2009-03-06 | 2015-09-02 | ラットガーズ,ザ・ステート・ユニバーシティ・オブ・ニュージャージー | 癌治療に用いられるメチレンジオキシベンゾ[i]フェナントリジン誘導体 |
WO2010104595A1 (en) * | 2009-03-11 | 2010-09-16 | Xintria Pharmaceutical Corporation, Inc. | Methods and compositions for the treatment of metabolic and cardiovascular disorders |
WO2010127363A1 (en) | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
US20140107505A1 (en) * | 2012-10-11 | 2014-04-17 | Alon Marmor | Determination of ventricular pressure and related values |
CA3019945A1 (en) | 2016-04-04 | 2017-10-12 | Rutgers, The State University Of New Jersey | Topoisomerase poisons |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL129028C (es) * | 1964-02-13 | |||
US3420834A (en) * | 1964-11-13 | 1969-01-07 | Roussel Uclaf | 2,3-dimethoxy-berbines substituted in the 10 position and process |
JPS4942700A (es) * | 1972-08-25 | 1974-04-22 | ||
US3920665A (en) * | 1972-10-19 | 1975-11-18 | Kanebo Ltd | Berbine compounds |
JPS523397B2 (es) * | 1972-11-20 | 1977-01-27 | ||
US3910938A (en) * | 1973-01-27 | 1975-10-07 | Kanebo Ltd | Berbine derivatives |
US4042592A (en) * | 1974-05-08 | 1977-08-16 | Kanebo, Ltd. | Novel dibenzo[a,g]quinolizinium compounds |
US4087426A (en) * | 1976-08-16 | 1978-05-02 | Research Corporation | Oxybisberberine and a process for its production |
SE426548B (sv) * | 1978-12-05 | 1983-01-31 | Haessle Ab | Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer |
-
1983
- 1983-05-12 IE IE1098/83A patent/IE55519B1/en not_active IP Right Cessation
- 1983-05-13 EP EP83902149A patent/EP0108147B1/en not_active Expired
- 1983-05-13 AU AU17063/83A patent/AU571184B2/en not_active Ceased
- 1983-05-13 WO PCT/US1983/000729 patent/WO1983003970A1/en active IP Right Grant
- 1983-05-13 CA CA000428157A patent/CA1220139A/en not_active Expired
- 1983-05-13 PT PT76690A patent/PT76690B/pt not_active IP Right Cessation
- 1983-05-13 DE DE8383902149T patent/DE3377695D1/de not_active Expired
- 1983-05-13 IL IL68690A patent/IL68690A0/xx active IP Right Grant
- 1983-05-13 GR GR71343A patent/GR79223B/el unknown
- 1983-05-13 IT IT48294/83A patent/IT1173712B/it active
- 1983-05-14 ES ES522754A patent/ES8703871A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL68690A0 (en) | 1983-09-30 |
IE55519B1 (en) | 1990-10-10 |
PT76690A (en) | 1983-06-01 |
IE831098L (en) | 1983-11-14 |
AU1706383A (en) | 1983-12-02 |
IT8348294A0 (it) | 1983-05-13 |
EP0108147A4 (en) | 1984-09-13 |
IT1173712B (it) | 1987-06-24 |
GR79223B (es) | 1984-10-22 |
PT76690B (en) | 1986-03-19 |
WO1983003970A1 (en) | 1983-11-24 |
DE3377695D1 (en) | 1988-09-22 |
ES522754A0 (es) | 1987-03-16 |
AU571184B2 (en) | 1988-04-14 |
CA1220139A (en) | 1987-04-07 |
EP0108147A1 (en) | 1984-05-16 |
EP0108147B1 (en) | 1988-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8703871A1 (es) | Procedimiento de obtener alcaloides del tipo de la berberina y similares. | |
JPS5272379A (en) | Separation of fluid | |
ES8801276A1 (es) | Procedimiento para preparar nuevos derivados imidazo | |
GB1514720A (en) | Preparation of hydroxyethyl starch | |
JPS5441191A (en) | Glucose-oxygen sensitive electrode | |
JPS57134419A (en) | Stable anticoagulant of blood | |
Jones et al. | Effect of protamine on plasma ionized calcium in the dog | |
NZ217592A (en) | Cardioplegia-inducing pharmaceutical composition containing potassium ions facilitated by adenosine | |
JPS54138126A (en) | Remedy for diabetes | |
ES473534A1 (es) | Procedimiento para la preparacion de analogos de prostaci- clina | |
JPS57116017A (en) | Antithrombogenetic or anticoagulative agent | |
AU2169677A (en) | Medicament to be taken orally for regulating the circulation of blood | |
Beavers et al. | Relationship of potassium and calcium to hypothermic ventricular fibrillation | |
JPS579787A (en) | Thiazinobenzimidazole derivative and its preparation | |
GB1520248A (en) | Sodium cromoglycate containing medicament | |
Knudsen et al. | The Effect On Serum-Thromboxan B2 Production, Platelet Aggregation, Serotonin Release, PF-4 And 6-Keto-PGF1αOf A Novel Specific Thromboxan A2 Synthetase-Inhibitor In Patients With Hyperactive Platelets | |
Dejana et al. | Stimulation of prostacyclin release by a new vasodilatory coumarin derivative (AD6) | |
JPS57108016A (en) | Antithrombotic agent | |
Ohata et al. | Carotid baroreceptor influences on peripheral circulatory and thermal responses during cold exposure | |
JPS56100719A (en) | Antirheumatic agent | |
JPS53127834A (en) | Anti-tumor preparation | |
Carreras et al. | Reduced Production Of 6-Ket0-PGF1α By Umbilical Artery In Pre-Eclampsia | |
Thandroyen et al. | Combined α-and β-adrenoceptor antagonism protects against reperfusion ventricular arrhythmias | |
FR2259823A1 (en) | N-beta-hydroxyethyl aziridines and iminothiazolidines prepn. - by redn. of ketones with bis-alkoxy sodium aluminium dihydride | |
JPS57108014A (en) | Antithrombotic agent |